| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.009 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |